On July 13, Johnson & Johnson acquired Calibra Medical , maker of the Finesse “insulin patch-pen” for type 1 and type 2 diabetes. The slimly designed Finesse (2...

Gary Scheiner searches for the happy medium between neglecting your diabetes care and being completely overwhelmed.

On December 11, Omada Health launched Prevent Now , an online version of the Diabetes Prevention Program (DPP). The landmark NIH-funded DPP study found that moderate...

(S)he said what!?

Friends for Life, the national Children with Diabetes (CWD) conference, took place in Orlando, Florida, from July 11 to July 15.

On August 17, the FDA approved Mylan’s new generic versions of Actos (pioglitazone), a once-daily oral tablet for the treatment of type 2 diabetes originally sold by...

(S)he said what!?

The Partnership for a Healthier America (PHA) will hold its second Building a Healthier Future Summit from March 6-8, 2013, in Washington, DC. We cannot wait to hear...

Jim Hirsch sheds light on the shocking conditions an inmate with type 1 diabetes is enduring while behind bars. You can help him by signing our petition to protest this...

On World Diabetes Day in San Francisco, Manny Hernandez of the Diabetes Hands Foundation (DHF) announced that the DHF had exceeded its goal to get 20,000 people to take...

Can a drug for type 2 diabetes work for those with type 1? How will a new basal insulin compare to Lantus?

diaTribe salutes director Jennifer Mackenzie for her emerging film Sugar Babies . The documentary examines the impact of type 1 and type 2 diabetes on children in...

The newest in CGM: learn about Dexcom’s redesigned, more accurate, and sleeker G4 Platinum system.

Amylin Pharmaceuticals, developer of the GLP-1 agonists Byetta and Bydureon ( recently acquired by Bristol-Myers Squibb ), has pledged to donate $5 to a diabetes charity...

James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat .

We like Practical Diabetology because it's straightforward, actionable, and smart — but, be warned, it's for physicians.

Frequent and careful blood glucose monitoring is unquestionably useful for people who take insulin, but is monitoring necessary for all patients

On August 29, J&J’s chronic pain drug Nucynta ER (tapentadol) was granted FDA approval for the management of the pain associated with diabetic peripheral neuropathy...

On February 1, the European Commission announced that it had approved Sanofi and Zealand Pharma’s GLP-1 agonist Lyxumia (lixisenatide) for type 2 diabetes. The drug is a...

Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.